HomeIndustry News › Peptides

‘I have the energy of a 21-year-old’: The peptide wellness boom taking over your social media – nzherald.co.nz

Peptides: ‘I have the energy of a 21-year-old’: The peptide wellness boom taking over your social media – nzherald.co.nz

Social media platforms have become flooded with influencers and wellness advocates promoting peptide therapies, creating a booming market for compounds like semaglutide, BPC-157, and various “anti-aging” peptides. What was once a niche area of medical research has exploded into a multi-billion dollar wellness trend, with celebrities, biohackers, and everyday consumers sharing their experiences with injectable peptides for weight loss, muscle building, skin rejuvenation, and longevity.

The surge in peptide popularity has been driven largely by the success of GLP-1 receptor agonists like Ozempic and Wegovy, which have become household names thanks to dramatic weight loss results documented across Instagram, TikTok, and YouTube. This mainstream acceptance has created a halo effect, lending credibility to a wide array of other peptide products—many of which lack the rigorous clinical testing that FDA-approved medications undergo. Online telehealth companies and compounding pharmacies have capitalized on this demand, offering peptide prescriptions with minimal oversight, while unregulated research peptide suppliers operate in legal gray areas.

The trend raises significant concerns among medical professionals and regulatory authorities. While some peptides like semaglutide have demonstrated clear clinical benefits in controlled trials, many others being promoted online have limited human safety data or are being used for off-label purposes without proper medical supervision. The American Medical Association and FDA have issued warnings about contaminated or counterfeit peptides sold through unverified online sources, and reports of adverse effects from improperly dosed or administered peptides have increased.

This peptide wellness boom represents a collision between legitimate medical innovation and unregulated direct-to-consumer marketing. As demand continues to grow, medical educators face the challenge of helping both healthcare providers and patients distinguish between evidence-based peptide therapies and potentially harmful wellness trends. The situation underscores the broader need for improved health literacy in the social media age, where viral anecdotes can overshadow clinical evidence and regulatory safeguards designed to protect patient safety.

← Previous “I’m just not comfortable with with myself” — Inside the grey market peptide boom - London Evening Standard Next → Menopause hormone therapy treatments would be covered by health insurance under Ohio bill - Ohio Capital Journal

Get the Weekly Digest

Research highlights, community picks, and expert insights — every week.

← Back to All News

Popular telehealth providers in this space

Disclosure: The links below are affiliate links — if you click through and make a purchase, GLPbase may earn a small commission at no additional cost to you. This section does not constitute medical advice or a recommendation to seek treatment. Any healthcare decisions are solely between you and your provider. These links do not affect the article above, which is independently researched and written before any affiliate links are added. Our editorial team does not receive commissions, and our analysis is never influenced by affiliate partnerships. For more details, see our Editorial Policy.